Unknown

Dataset Information

0

Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.


ABSTRACT: In the last step of estrogen biosynthesis, aromatase enzyme catalyzes the conversion of androgens to estrogens. Aromatase inhibition is an important way to control estrogen-related diseases and estrogen levels. In this study, sixteen of benzimidazole-triazolothiadiazine derivatives have been synthesized and studied as potent aromatase inhibitors. First, these compounds were tested for their anti-cancer properties against human breast cancer cell line (MCF-7). The most active compounds 5c, 5e, 5k, and 5m on MCF-7 cell line were subject to further in vitro aromatase enzyme inhibition assays to determine the possible mechanisms of action underlying their activity. Compound 5e showed slight less potent aromatase inhibitory activity than that of letrozole with IC50 = 0.032 ± 0.042 µM, compared to IC50 = 0.024 ± 0.001 µM for letrozole. Furthermore, compound 5e and reference drug letrozole were docked into human placental aromatase enzyme to predict their possible binding modes with the enzyme. Finally, ADME parameters (absorption, distribution, metabolism, and excretion) of synthesized compounds (5a-5p) were calculated by QikProp 4.8 software.

SUBMITTER: Acar Cevik U 

PROVIDER: S-EPMC7180718 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.

Acar Çevik Ulviye U   Kaya Çavuşoğlu Betül B   Sağlık Begüm Nurpelin BN   Osmaniye Derya D   Levent Serkan S   Ilgın Sinem S   Özkay Yusuf Y   Kaplancıklı Zafer Asım ZA  

Molecules (Basel, Switzerland) 20200402 7


In the last step of estrogen biosynthesis, aromatase enzyme catalyzes the conversion of androgens to estrogens. Aromatase inhibition is an important way to control estrogen-related diseases and estrogen levels. In this study, sixteen of benzimidazole-triazolothiadiazine derivatives have been synthesized and studied as potent aromatase inhibitors. First, these compounds were tested for their anti-cancer properties against human breast cancer cell line (MCF-7). The most active compounds <b>5c</b>,  ...[more]

Similar Datasets

| S-EPMC10503985 | biostudies-literature
| S-EPMC10994708 | biostudies-literature
| S-EPMC8911400 | biostudies-literature
| S-EPMC5362474 | biostudies-literature
| S-EPMC9097188 | biostudies-literature
| S-EPMC6429502 | biostudies-literature
| S-EPMC10819888 | biostudies-literature
| S-EPMC6963781 | biostudies-literature
| S-EPMC9557063 | biostudies-literature
| S-EPMC6149685 | biostudies-literature